ARTICLE | Company News
Sosei, Imperial College London inflammation, autoimmune news
February 8, 2016 8:00 AM UTC
Sosei’s Heptares Therapeutics Ltd. subsidiary is committing up to L5 million ($7.1 million) over the next three years to fund the new ORBIT (Opportunities in Receptor Biology for Industrial Translati...